About: Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Sector: Healthcare
Industry: Medical Devices
Latest price: $5.70 (+5.17%)
AVR NASDAQ Anteris Technologies Global Corp. Common Stock
Anteris Technologies Global Corp. Common Stock share price
AVR price activity
Last Price
$5.700
Change (24hr)
0.28 USD (5.17%)
Volume
1.34M
Volume (4w avg)
-
Open
$5.43
Day Range
$5.37 - $5.72
Previous Close
$5.42
Last Trade
16 Nov, 9:00 pm GMT+0
Delayed
16 Nov, 9:00 pm GMT+0
AVR price performance
Delayed
16 Nov, 9:00 pm GMT+0
AVR details
AVR Market Signals